Latest Tokyo Brief coverage on Meiji Holdings Co., Ltd., tracking filings, financial news, and market signals from Japan.
TSE:2269
Meiji will recapitalise a Hokkaido corn processor with one new share to erase its negative net assets, then transfer the company to Yoshimura Food Holdings on a planned November 1 date, at an undisclosed price.
Kyorin Pharmaceutical has signed to sell its generics subsidiary, including the Takaoka and Inami plants, to a venture owned by Daito, Meiji Seika Pharma and DBJ, with closing planned for April 1, 2027 and authorized generics carved out.
Meiji Holdings' new Shanghai dairy-sales subsidiary, capitalized above 650 million yuan and wholly owned indirectly, crossed the size threshold that forces disclosure under Japan's securities law.
Meiji Holdings is selling its loss-making China milk, yogurt and B2B business to a dairy group it partly owns for about ¥7.6bn, while holding onto yogurt intellectual property and its Guangzhou plant, which switches to making cacao products.
Current holdings disclosed by tracked funds.